BSE Live
Apr 20, 16:01Prev. Close
654.40
Open Price
656.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Apr 20, 15:58Prev. Close
655.70
Open Price
657.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
664.45 (1185)
| Profit & Loss account of Granules India (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| INCOME | ||||||
| Revenue From Operations [Gross] | 2,967.57 | 3,740.13 | 3,915.62 | 3,200.69 | 3,094.00 | |
| Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue From Operations [Net] | 2,967.57 | 3,740.13 | 3,915.62 | 3,200.69 | 3,094.00 | |
| Total Operating Revenues | 3,030.16 | 3,755.09 | 3,931.20 | 3,238.44 | 3,134.98 | |
| Other Income | 40.68 | 5.78 | 9.93 | 17.51 | 13.72 | |
| Total Revenue | 3,070.84 | 3,760.87 | 3,941.13 | 3,255.95 | 3,148.71 | |
| EXPENSES | ||||||
| Cost Of Materials Consumed | 1,373.90 | 1,927.12 | 2,099.93 | 1,864.16 | 1,502.19 | |
| Purchase Of Stock-In Trade | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating And Direct Expenses | 3.58 | 9.98 | 5.46 | 4.08 | 10.47 | |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -29.80 | -20.21 | 61.52 | -106.41 | 7.45 | |
| Employee Benefit Expenses | 382.34 | 380.61 | 330.07 | 282.80 | 318.25 | |
| Finance Costs | 62.78 | 72.00 | 38.67 | 16.35 | 23.77 | |
| Depreciation And Amortisation Expenses | 146.23 | 143.85 | 145.56 | 126.16 | 118.45 | |
| Other Expenses | 731.33 | 656.22 | 595.98 | 549.16 | 435.25 | |
| Total Expenses | 2,674.37 | 3,169.58 | 3,277.19 | 2,736.30 | 2,415.84 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 396.47 | 591.29 | 663.94 | 519.65 | 732.87 | |
| Exceptional Items | 30.75 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Profit/Loss Before Tax | 427.22 | 591.29 | 663.94 | 519.65 | 732.87 | |
| Tax Expenses-Continued Operations | ||||||
| Current Tax | 109.88 | 150.61 | 170.21 | 133.51 | 197.06 | |
| Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax | -1.99 | 4.77 | -5.05 | -0.38 | -16.97 | |
| Tax For Earlier Years | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Tax Expenses | 107.89 | 155.37 | 165.16 | 133.13 | 180.09 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 319.34 | 435.92 | 498.79 | 386.51 | 552.78 | |
| Profit/Loss From Continuing Operations | 319.34 | 435.92 | 498.79 | 386.51 | 552.78 | |
| Profit/Loss For The Period | 319.34 | 435.92 | 498.79 | 386.51 | 552.78 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| EARNINGS PER SHARE | ||||||
| Basic EPS (Rs.) | 13.17 | 18.00 | 20.32 | 15.60 | 22.18 | |
| Diluted EPS (Rs.) | 13.17 | 17.99 | 20.30 | 15.55 | 22.09 | |
| VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
| Equity Share Dividend | 36.36 | 36.31 | 18.62 | 37.17 | 24.75 | |
| Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Equity Dividend Rate (%) | 150.00 | 150.00 | 150.00 | 150.00 | 150.00 |
01.04.2026
Buy Granules India; target of Rs 800: Emkay Global Financial
01.04.2026
Granules India shares up 2% after arm gets VAI status post USFDA inspection
01.04.2026
30.03.2026
27.01.2026
Granules India Consolidated December 2025 Net Sales at Rs 1,387.94 crore, up 22% Y-o-Y
27.01.2026
Granules India Standalone December 2025 Net Sales at Rs 895.32 crore, up 6.31% Y-o-Y
26.11.2025
Granules India Consolidated September 2025 Net Sales at Rs 1,296.99 crore, up 34.18% Y-o-Y
24.11.2025
Granules India Standalone September 2025 Net Sales at Rs 891.61 crore, up 56.98% Y-o-Y
13.04.2026
13.04.2026
10.04.2026
09.04.2026
21.01.2026
Dr Reddy's posts smaller-than-expected Q3 profit fall on domestic boost
12.11.2025
07.11.2025
24.10.2025
Dr Reddy's Q2 Results: Net profit rises 7% to Rs 1,347 crore, misses estimates
17.07.2025
Sun Pharma Q1 PAT seen up 8.4% YoY to Rs 3,132.7 cr: ICICI Securities
17.07.2025
Biocon Q1 PAT may dip 72% YoY to Rs 91.1 cr: ICICI Securities
17.07.2025
Cipla Q1 PAT seen up 2% YoY to Rs 1,246.7 cr: ICICI Securities
29.01.2025
Sun Pharma Q3 Preview: Double-digit India, US sales to power mid-teen profit growth